SEP 02, 2019 03:56 PM PDT

Treating glioblastomas through the bloodstream

New research published in Nature Communications details a novel immunotherapy that is capable of treating brain cancer via the bloodstream. Although only proven thus far in mice, the nano-immunotherapy has the potential to change the way we treat glioblastoma, the most common and aggressive form of brain cancer, forever.

New research uses nano-immunotherapy to target brain tumors via the bloodstream. Photo: Pixabay

The technology uses checkpoint inhibitor drugs in order to disarm brain tumors that fight against the immune system. But the key in this therapy is its ability to cross the blood-brain barrier – at least in mice.

"Although our findings were not made in humans," says senior study author Julia Y. Ljubimova, a professor of neurosurgery and biomedical sciences at Cedars-Sinai Medical Center in Los Angeles, CA, "they bring us closer to developing a treatment that might effectively attack brain tumors with [systemic] drug administration."

How did they do this? Well, because brain tumors suppress attack from anticancer cells using macrophages and T regulatory cells, the researchers decided to try to block them using checkpoint inhibitor drugs so that the immune system can properly activate cancer-killing cells. Using a small transporter protein to carry an inhibitor drug across the blood-brain barrier, the researchers were able to target the macrophages and T regulatory cells systemically, i.e. through the bloodstream.

Although brain cancer is not particularly common, it does account for more than its fair share of cancer deaths. According to the National Cancer Institute, 23,820 people in the United States will find out that they have brain cancer in 2019, and 17,760 will die of the disease in this same year.

While the new immunotherapy has a ways to go before it will be ready for human trials, Professor Ljubimova says, "We hope that by delivering multifunctional new-generation drugs through the blood-brain barrier, we can explore new therapies for many neurological conditions."

Sources: Medical News Today, Nature Communications

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
OCT 22, 2019
Cancer
OCT 22, 2019
Understanding osteosarcoma in kids and dogs
New research published in the Nature journal, Communications Biology, shows evidence for a comparative study that scientists could use to improve treatment...
OCT 22, 2019
Cancer
OCT 22, 2019
New research targets pancreatic cancer tumors' environment
New research published in the journal Nature Communications highlights the inner workings of how pancreatic cancer cells spread. Pancreatic cancer is one o...
OCT 22, 2019
Cell & Molecular Biology
OCT 22, 2019
How the Sun's Rays Damage the Skin
We all need sunlight, but it's very easy to get too much. Sunlight is the main source of the ultraviolet radiation we're exposed to....
OCT 22, 2019
Cancer
OCT 22, 2019
One third of women don't take advantage of free cancer screenings
Have you ever received a cancer screening? If you haven’t, you’re not alone. New research from King's College London and Queen Mary Univers...
OCT 22, 2019
Cancer
OCT 22, 2019
Detecting breast cancer in men
New research published recently in the journal Radiology suggests the need for improved mammography screening for men who are at high risk for breast cance...
OCT 22, 2019
Cancer
OCT 22, 2019
It's not all bad: cancer and aging
Research published recently in the journal Aging Cell highlights the complexities of the interactions that occur during the aging process from the angle of...
Loading Comments...